S.A. Volchenkov Volchenkov scite author profile

Conclusion: Due to advanced age, comorbidities and/or high ECOG, only 54% of patients with DLBCL and HGL were chosen for curative R-ChT. Only 9 are alive with a follow-up time ≥18 months. The studied patients presented characteristics, risk factors and unsatisfactory responses to R-ChT in R/R, as described. Thus, we emphasize the adjusted selection of treatment strategies as a way to improve the prognosis.EA -previously submitted to regional or national meetings (up to 1000 attendees).

show abstract

Approaches to the mobilization of hematopoietic stem cells: a literature review

Elkhova¹,

Zyuzgin²,

Volchenkov³

et al. 2022

Pharmateca

View full text Add to dashboard Cite

Nutritional support during high dose chemotherapy with autologous hematopoietic stem cell transplantation (autohsct) in patients with Hodgkin's lymphoma. (interim results)

Volchenkov

Zyuzgin

Lyubimov

et al. 2021

Clinical Nutrition ESPEN

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.